The U.S. Food and Drug Administration has Ferriprox (deferiprone) for the treatment of iron overload caused by blood transfusions in patients with thalassemia. Read more.
FDA approves Ferriprox for thalassemia patients with iron overload from blood transfusions
Most Recent Content
For Nurse Practitioners
Menopause and Sleep Problems
Data shows that sleep disturbances increase in prevalence during the menopausal transition, with the most common complaint being nighttime awakenings.
Take our quick three-question survey...
